Published on
Thanks to a recent initiative at CHOP, patients newly diagnosed with B-cell and T-cell ALL, and lymphoblastic lymphoma, now go home on average 9 days after diagnosis — that's 3 weeks sooner than previous stays.
Published on
CHOP is working to improve personalized cell therapy for children. Using younger T cells may offer better results against certain types of leukemia and lymphoma.
Published on
The history of our understanding and approach to cancer are at the center of CANCER: THE EMPEROR OF ALL MALADIES. The documentary will air in three parts on March 30, 31 and April 1 at 9 p.m. ET on PBS, with the final chapter featuring CHOP.
Published on
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.